Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A06014 | 33037968 | Dig Dis Sci | Incident Dementia in Elderly Patients with Nonalcoholic Fatty Liver Disease in Germany. | 2020 | Details |
| A06015 | 33037853 | Hepatol Res | Prevalence of anti-Hepatitis E antibodies and impact on disease severity in non-alcoholic fatty liver disease. | 2020 | Details |
| A06016 | 33037768 | Liver Int | Intestinal permeability in human nonalcoholic fatty liver disease: A systematic review and meta-analysis. | 2020 | Details |
| A06017 | 33037751 | Phytother Res | Apple polyphenol extract alleviates lipid accumulation in free-fatty-acid-exposed HepG2 cells via activating autophagy mediated by SIRT1/AMPK signaling. | 2020 | Details |
| A06018 | 33037656 | Clin Endocrinol (Oxf) | Effect of recombinant human growth hormone on liver fat content in young adults with nonalcoholic fatty liver disease. | 2020 | Details |
| A06019 | 33037652 | J Food Sci | Coniferaldehyde ameliorates the lipid and glucose metabolism in palmitic acid-induced HepG2 cells via the LKB1/AMPK signaling pathway. | 2020 | Details |
| A06020 | 33037249 | Sci Rep | Pathophysiology of high fat diet induced obesity: impact of probiotic banana juice on obesity associated complications and hepatosteatosis. | 2020 | Details |
| A06021 | 33037056 | Gut | Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort. | 2020 | Details |
| A06022 | 33036939 | Surg Obes Relat Dis | Recent advances in the mechanisms underlying the beneficial effects of bariatric and metabolic surgery. | 2020 | Details |
| A06023 | 33036418 | Diagnostics (Basel) | Optimization of Point-Shear Wave Elastography by Skin-to-Liver Distance to Assess Liver Fibrosis in Patients Undergoing Bariatric Surgery. | 2020 | Details |
| A06024 | 33036387 | Cells | Discovery and Targeting of the Signaling Controls of PNPLA3 to Effectively Reduce Transcription, Expression, and Function in Pre-Clinical NAFLD/NASH Settings. | 2020 | Details |
| A06025 | 33036257 | Cells | Playing Jekyll and Hyde-The Dual Role of Lipids in Fatty Liver Disease. | 2020 | Details |
| A06026 | 33036179 | J Clin Med | One Year's Treatment with the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide Decreases Hepatic Fat Content in Women with Nonalcoholic Fatty Liver Disease and Prior Gestational Diabetes Mellitus in a Randomized, Placebo-Controlled Trial. | 2020 | Details |
| A06027 | 33035599 | Diabetes Res Clin Pract | Liraglutide or insulin glargine treatments improves hepatic fat in obese patients with type 2 diabetes and nonalcoholic fatty liver disease in twenty-six weeks: A randomized placebo-controlled trial. | 2020 | Details |
| A06028 | 33035588 | Life Sci | Nicotinamide and ascorbic acid nanoparticles against the hepatic insult induced in rats by high fat high fructose diet: A comparative study. | 2020 | Details |
| A06029 | 33034671 | Abdom Radiol (NY) | Quantification of liver function using gadoxetic acid-enhanced MRI. | 2020 | Details |
| A06030 | 33034193 | J Agric Food Chem | High-Fat Proteins Drive Dynamic Changes in Gut Microbiota, Hepatic Metabolome, and Endotoxemia-TLR-4-NFκB-Mediated Inflammation in Mice. | 2020 | Details |
| A06032 | 33033573 | World J Hepatol | Non-alcoholic fatty liver disease later diagnosed as myotonic dystrophy. | 2020 | Details |
| A06033 | 33033571 | World J Hepatol | Can gadoxetic acid-enhanced magnetic resonance imaging be used to avoid liver biopsy in patients with nonalcoholic fatty liver disease? | 2020 | Details |
| A06034 | 33033564 | World J Hepatol | Clinical implications, diagnosis, and management of diabetes in patients with chronic liver diseases. | 2020 | Details |
| A06036 | 33032515 | Curr Med Imaging | Evaluation and Comparative Correlation of Abdominal Fat Related Parameters in Obese and Non-obese Groups Using Computed Tomography. | 2021 | Details |
| A06038 | 33032263 | J Endocrinol | Lactobacillus pentosus strain S-PT84 improves steatohepatitis by maintaining gut permeability. | 2020 | Details |
| A06039 | 33031970 | Ann Hepatol | Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease. | 2020 | Details |
| A06040 | 33031969 | Ann Hepatol | Non-invasive diagnosis of non-alcoholic fatty liver disease using an algorithm combining clinical indexes and ultrasonographic measures. | 2020 | Details |
| A06042 | 33031758 | Lancet Gastroenterol Hepatol | Redefining fatty liver disease: an international patient perspective. | 2020 | Details |
| A06043 | 33031439 | PLoS One | In-hospital mortality is associated with inflammatory response in NAFLD patients admitted for COVID-19. | 2020 | Details |
| A06044 | 33030804 | J Diabetes Investig | Association of the Non-Alcoholic Fatty Liver Disease Fibrosis Score with subclinical myocardial remodeling in patients with type 2 diabetes: A cross-sectional study in China. | 2021 | Details |
| A06045 | 33029298 | Anim Cells Syst (Seoul) | Capsaicin suppresses liver fat accumulation in high-fat diet-induced NAFLD mice. | 2020 | Details |
| A06046 | 33029240 | Acta Endocrinol (Buchar) | THE EFFECTS OF REALSIL (SILYBIN-PHOSPHOLIPID-VITAMIN E COMPLEX) ON LIVER ENZYMES IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) OR NON-ALCOHOLIC STEATO-HEPATITIS (NASH): A SYSTEMATIC REVIEW AND META-ANALYSIS OF RCTS. | 2022 | Details |
| A06047 | 33029058 | J Clin Exp Hepatol | Hepatocellular Carcinoma Screening and Nonalcoholic Fatty Liver Disease: How is it Different? | 2020 | Details |
| A06048 | 33028928 | Sci Rep | The effects of fructose and metabolic inhibition on hepatocellular carcinoma. | 2020 | Details |
| A06049 | 33028338 | Lipids Health Dis | The triglyceride-glucose index is associated with the severity of hepatic steatosis and the presence of liver fibrosis in non-alcoholic fatty liver disease: a cross-sectional study in Chinese adults. | 2020 | Details |
| A06050 | 33027743 | Biomed Pharmacother | Sagittaria sagittifolia polysaccharide interferes with arachidonic acid metabolism in non-alcoholic fatty liver disease mice via Nrf2/HO-1 signaling pathway. | 2020 | Details |
| A06051 | 33027714 | Pharmacol Res | FATP2-targeted therapies - A role beyond fatty liver disease. | 2020 | Details |
| A06052 | 33027657 | Cell Rep | Genetic and Microbial Associations to Plasma and Fecal Bile Acids in Obesity Relate to Plasma Lipids and Liver Fat Content. | 2020 | Details |
| A06053 | 33027655 | Cell Rep | The Lipid Handling Capacity of Subcutaneous Fat Is Programmed by mTORC2 during Development. | 2020 | Details |
| A06054 | 33027082 | Am J Gastroenterol | Effects of Statin Use on the Development and Progression of Nonalcoholic Fatty Liver Disease: A Nationwide Nested Case-Control Study. | 2021 | Details |
| A06055 | 33026561 | EJNMMI Res | Quantitative evaluation of hepatic integrin αvβ3 expression by positron emission tomography imaging using 18F-FPP-RGD2 in rats with non-alcoholic steatohepatitis. | 2020 | Details |
| A06056 | 33026380 | Food Funct | Gut inflammation exacerbates hepatic injury in C57BL/6J mice via gut-vascular barrier dysfunction with high-fat-incorporated meat protein diets. | 2020 | Details |
| A06057 | 33025657 | Liver Int | Recent advances targeting C-C chemokine receptor type 2 for liver diseases in monocyte/macrophage. | 2020 | Details |
| A06058 | 33025629 | NMR Biomed | In vivo absolute quantification of hepatic γ-ATP concentration in mice using 31 P MRS at 11.7 T. | 2020 | Details |
| A06059 | 33025153 | Abdom Radiol (NY) | Liver fat quantification: where do we stand? | 2020 | Details |
| A06060 | 33024915 | Hepatol Commun | Therapeutic Targeting of Myeloperoxidase Attenuates NASH in Mice. | 2020 | Details |
| A06061 | 33024914 | Hepatol Commun | LPCN 1144 Resolves NAFLD in Hypogonadal Males. | 2020 | Details |
| A06062 | 33024913 | Hepatol Commun | Differential Outcomes and Clinical Challenges of NAFLD With Extreme Obesity. | 2020 | Details |
| A06063 | 33024911 | Hepatol Commun | Developmental Programming of NAFLD by Parental Obesity. | 2020 | Details |
| A06064 | 33024398 | World J Gastroenterol | Pediatric non-alcoholic fatty liver disease and kidney function: Effect of HSD17B13 variant. | 2020 | Details |
| A06065 | 33024131 | Sci Rep | Characterization of two types of intranuclear hepatocellular inclusions in NAFLD. | 2020 | Details |
| A06067 | 33022942 | Life (Basel) | Plasma Long Noncoding RNA LeXis is a Potential Diagnostic Marker for Non-Alcoholic Steatohepatitis. | 2020 | Details |
| A06068 | 33022287 | Food Chem Toxicol | MEHP/ethanol co-exposure favors the death of steatotic hepatocytes, possibly through CYP4A and ADH involvement. | 2020 | Details |
| A06069 | 33020474 | Nat Commun | Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD. | 2020 | Details |
| A06070 | 33020450 | Microorganisms | A New Endemic of Concomitant Nonalcoholic Fatty Liver Disease and Chronic Hepatitis B. | 2020 | Details |
| A06071 | 33017610 | J Nutr Biochem | Liver lipidome signature and metabolic pathways in nonalcoholic fatty liver disease induced by a high-sugar diet. | 2020 | Details |
| A06072 | 33017572 | Life Sci | Nonalcoholic fatty liver disease and colorectal cancer: Correlation and missing links. | 2020 | Details |
| A06073 | 33016540 | Aliment Pharmacol Ther | Patterns and predictors of mortality and disease progression among patients with non-alcoholic fatty liver disease. | 2020 | Details |
| A06074 | 33015726 | Curr Diab Rep | Role of Agents for the Treatment of Diabetes in the Management of Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A06075 | 33015098 | Front Med (Lausanne) | Bile Acids and FXR: Novel Targets for Liver Diseases. | 2020 | Details |
| A06076 | 33015093 | Front Med (Lausanne) | Association Between Leukocyte Mitochondrial DNA Copy Number and Non-alcoholic Fatty Liver Disease in a Chinese Population Is Mediated by 8-Oxo-2'-Deoxyguanosine. | 2020 | Details |
| A06077 | 33014604 | Biomed Opt Express | Intravital longitudinal imaging of hepatic lipid droplet accumulation in a murine model for nonalcoholic fatty liver disease. | 2020 | Details |
| A06078 | 33014333 | Cell Biosci | Phloretin ameliorates hepatic steatosis through regulation of lipogenesis and Sirt1/AMPK signaling in obese mice. | 2020 | Details |
| A06079 | 33014047 | Int J Endocrinol | Comparison of Erythrocyte Membrane Lipid Profiles between NAFLD Patients with or without Hyperlipidemia. | 2020 | Details |
| A06080 | 33013934 | Front Immunol | CD4+ T Cells Mediate the Development of Liver Fibrosis in High Fat Diet-Induced NAFLD in Humanized Mice. | 2020 | Details |
| A06081 | 33013688 | Front Endocrinol (Lausanne) | Abdominal Adiposity and Total Body Fat as Predictors of Cardiometabolic Health in Children and Adolescents With Obesity. | 2020 | Details |
| A06082 | 33012740 | J Atheroscler Thromb | Phenotypic Changes in Macrophage Activation in a Model of Nonalcoholic Fatty Liver Disease using Microminipigs. | 2020 | Details |
| A06085 | 33012444 | Clin Liver Dis | The Changing Global Epidemiology of Hepatocellular Carcinoma. | 2020 | Details |
| A06086 | 33011976 | Acta Psychiatr Scand | Non-alcoholic fatty liver disease in a sample of individuals with bipolar disorders: results from the FACE-BD cohort. | 2020 | Details |
| A06087 | 33011499 | Diabetes Metab Syndr | Comparative effectiveness of glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors on noninvasive indices of hepatic steatosis and fibrosis in patients with type 2 diabetes mellitus. | 2020 | Details |
| A06088 | 33011191 | Prog Lipid Res | The multi-faces of Angptl8 in health and disease: Novel functions beyond lipoprotein lipase modulation. | 2020 | Details |
| A06089 | 33010471 | Mol Metab | Dysregulated lipid metabolism links NAFLD to cardiovascular disease. | 2020 | Details |
| A06090 | 33010412 | Clin Gastroenterol Hepatol | Testosterone is Associated With Nonalcoholic Steatohepatitis and Fibrosis in Premenopausal Women With NAFLD. | 2020 | Details |
| A06091 | 33010409 | Clin Gastroenterol Hepatol | Liver Stiffness by Magnetic Resonance Elastography Predicts Future Cirrhosis, Decompensation, and Death in NAFLD. | 2020 | Details |
| A06092 | 33010248 | Gastroenterology | Steatohepatitis Impairs T-cell-Directed Immunotherapies Against Liver Tumors in Mice. | 2020 | Details |
| A06093 | 33010191 | Diabetes Metab Res Rev | Effects of sodium-glucose co-transporter 2 inhibitors on liver parameters and steatosis: A meta-analysis of randomized clinical trials. | 2020 | Details |
| A06094 | 33010062 | Biotechnol Appl Biochem | Circulating mRNA and plasma levels of osteoprotegerin and receptor activator of NF-κB ligand in nonalcoholic fatty liver disease. | 2020 | Details |
| A06095 | 33009206 | J Chin Med Assoc | Genetic variations of three important antioxidative enzymes SOD2, CAT, and GPX1 in nonalcoholic steatohepatitis. | 2021 | Details |
| A06096 | 33009010 | AIDS | Liver steatosis and nonalcoholic fatty liver disease with fibrosis are predictors of frailty in people living with HIV. | 2020 | Details |
| A06097 | 33008924 | J Lipid Res | Insulin resistance dysregulates CYP7B1 leading to oxysterol accumulation: a pathway for NAFL to NASH transition. | 2020 | Details |
| A06098 | 33007859 | Biology (Basel) | Cholesterol Homeostasis: An In Silico Investigation into How Aging Disrupts Its Key Hepatic Regulatory Mechanisms. | 2020 | Details |
| A06099 | 33007695 | Food Chem | Polyphenols of cambuci (Campomanesia phaea (O. Berg.)) fruit ameliorate insulin resistance and hepatic steatosis in obese mice. | 2020 | Details |
| A06100 | 33007508 | Clin Gastroenterol Hepatol | Association Between Lipoprotein Particles and Atherosclerotic Events in Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A06101 | 33007507 | Clin Gastroenterol Hepatol | The Clinical Spectrum and Diagnosis of Oxaliplatin Liver Injury in the Era of Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A06102 | 33007418 | Pharmacol Res | Endoplasmic reticulum stress and protein degradation in chronic liver disease. | 2020 | Details |
| A06103 | 33007261 | Cell | One Ring to Rule Them All: Mitochondrial Circular RNAs Control Mitochondrial Function. | 2020 | Details |
| A06104 | 33006810 | Helicobacter | Associations between Helicobacter pylori with nonalcoholic fatty liver disease and other metabolic conditions in Guatemala. | 2020 | Details |
| A06105 | 33006712 | Mol Biol Rep | Low-dose trans-resveratrol induce poly(ADP)-ribosylation-dependent increase of the PPAR-γ protein expression level in the in vitro model of non-alcoholic fatty liver disease. | 2020 | Details |
| A06106 | 33006125 | Adv Ther | Clinical Characteristics of a Non-Alcoholic Fatty Liver Disease Population Across the Fibrosis Spectrum Measured by Magnetic Resonance Elastography: Analysis of Screening Data. | 2020 | Details |
| A06107 | 33005474 | Liver Res | MiR-22 as a metabolic silencer and liver tumor suppressor. | 2020 | Details |
| A06108 | 33005011 | Lab Invest | Osr1 regulates hepatic inflammation and cell survival in the progression of non-alcoholic fatty liver disease. | 2020 | Details |
| A06109 | 33004402 | BMJ Open Diabetes Res Care | Metabolic and energetic benefits of microRNA-22 inhibition. | 2020 | Details |
| A06110 | 33004251 | Rev Gastroenterol Mex (Engl Ed) | Clinical utility of transient elastography as an imaging tool to assess the short-term impact of laparoscopic sleeve gastrectomy, together with clinical and biochemical parameters and clinico-biochemical indices, on obese patients with nonalcoholic fatty liver disease: An Egyptian pilot study. | 2020 | Details |
| A06111 | 33003574 | J Clin Med | Non-Alcoholic Fatty Liver Disease Markers Associated with Fasting Serum Insulin and Urinary Albumin Excretion Independent of Fasting Plasma Glucose. | 2020 | Details |
| A06112 | 33002297 | Mol Nutr Food Res | Huangjinya Black Tea Alleviates Obesity and Insulin Resistance via Modulating Fecal Metabolome in High-Fat Diet-Fed Mice. | 2020 | Details |
| A06113 | 33002003 | PLoS One | REV-ERB agonism improves liver pathology in a mouse model of NASH. | 2020 | Details |
| A06114 | 33001570 | Diabetes Obes Metab | Plasma proteome profiles treatment efficacy of incretin dual agonism in diet-induced obese female and male mice. | 2020 | Details |
| A06116 | 32999906 | GE Port J Gastroenterol | Gastrointestinal Microbiome - What We Need to Know in Clinical Practice. | 2020 | Details |
| A06117 | 32998777 | Lipids Health Dis | Signaling and other functions of lipids in autophagy: a review. | 2020 | Details |
| A06118 | 32998725 | BMC Med | Non-alcoholic fatty liver disease (NAFLD) as a neglected metabolic companion of psychiatric disorders: common pathways and future approaches. | 2020 | Details |
| A06119 | 32998280 | Metabolites | Neuronal Lipoprotein Lipase Deficiency Alters Neuronal Function and Hepatic Metabolism. | 2020 | Details |
| A06120 | 32998257 | Cancers (Basel) | Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease: A Step Forward for Better Evaluation Using Ultrasound Elastography. | 2020 | Details |
| A06121 | 32998139 | Oncology | TERT Promoter Mutation in Serum Cell-Free DNA Is a Diagnostic Marker of Primary Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease. | 2020 | Details |